Dana Jones
Gerontology · Teaneck, NJNPI 1639620958
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $96,303 of the $149,769 with a category attached, or 64.3%. 32 manufacturers reported payments, led by EMD Serono, Inc. at 58.6% of the total. 2025 is the largest year on record at $49,844, 7.3 times the $6,783 reported in 2021. Among gerontology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 794 payments — averaging $188.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$88K
- TG Therapeutics, Inc.$25K
- Vanda Pharmaceuticals Inc.$12K
- Johnson & Johnson$9K
- Genentech USA, Inc.$3K
- Bristol Myers Squibb$2K
- plus $12K from 26 others
What the payments were for
- Consulting fees$5,9004%
- Speaking & faculty fees$96,30364%
- Travel & lodging$21,97315%
- Food & beverage$25,49817%
- Education$950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 209 | $87,801 |
| TG Therapeutics, Inc. | 84 | $24,846 |
| Vanda Pharmaceuticals Inc. | 29 | $11,523 |
| Johnson & Johnson | 46 | $9,263 |
| Genentech USA, Inc. | 45 | $2,533 |
| Bristol Myers Squibb | 90 | $2,240 |
| Amgen(2 entities) | 31 | $2,144 |
| Biogen | 83 | $2,074 |
| E.r. Squibb & Sons, L.L.C. | 6 | $1,692 |
| Janssen Scientific Affairs, LLC | 2 | $1,040 |
| Philips North America LLC | 32 | $1,004 |
| Novartis | 53 | $978 |
| Sanofi | 11 | $685 |
| Biohaven Pharmaceuticals, Inc. | 8 | $556 |
| AbbVie(2 entities) | 10 | $240 |
| Mallinckrodt Hospital Products Inc. | 11 | $195 |
| ANI Pharmaceuticals, Inc. | 10 | $189 |
| Teva Pharmaceuticals USA, Inc. | 10 | $188 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $145 |
| Cycle Pharmaceuticals Inc | 4 | $89 |
| Mylan Specialty L.p. | 3 | $53 |
| AstraZeneca | 3 | $51 |
| Banner Life Sciences, LLC | 3 | $46 |
| Boston Scientific | 1 | $37 |
| Genentech, Inc. | 1 | $28 |
| Stryker | 1 | $28 |
| Avanir Pharmaceuticals, Inc. | 2 | $26 |
| Pfizer | 1 | $17 |
| Acorda Therapeutics, Inc | 1 | $15 |
| Bayer | 1 | $14 |
| Advanced Respiratory, Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mavenclad$75,305
- BRIUMVI$23,891
- Ponvory$19,713
- UPLIZNA$1,689
- OCREVUS$1,559
- ZEPOSIA$1,415
- NURTEC ODT$502
- TYSABRI$276
- inCourage$265
- Enspryng$249
- Ocrevus Zunovo$156
- Vumerity$125
- BOTOX$123
- (8876) Vest Therapy Und$118
- (AK6) Vest Therapy$100
How this compares
$149,769 in reported general payments places this provider in the 95th percentile of 374 gerontology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AubagioTeriflunomide | 29 | $263,259 |
| CopaxoneGlatiramer Acetate | 14 | $101,902 |
| AmpyraDalfampridine | 13 | $82,136 |
| ProvigilModafinil | 17 | $72,380 |
| Dalfampridine ErDalfampridine | 19 | $3,867 |
| Modafinil | 27 | $1,278 |
| Gabapentin | 45 | $921 |
| Baclofen | 38 | $660 |
| Methylphenidate Hcl | 13 | $478 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 20 | $425 |
| Tizanidine Hcl | 20 | $370 |
| Pregabalin | 13 | $335 |
| Escitalopram Oxalate | 13 | $204 |
| Zolpidem Tartrate | 20 | $147 |
| Alprazolam | 18 | $135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SanofiAubagio | $685 | $263,25929 claims |
| Teva Pharmaceuticals USA, Inc.Copaxone | $188 | $101,90214 claims |
| Acorda Therapeutics, IncAmpyra | $15 | $82,13613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 374 gerontology providers in New Jersey.
Other gerontology in Teaneck
- Daniel HuqTeaneck$6K
- Kristyn PapageorgiouTeaneck$2K
- Jennifer FoxFlemington$76K
- Susan HermidaBrick$33K
- Jihane SaadeNorth Bergen$9K
- Joseph RudolphCamden$8K
- Jennifer LernerNew Brunswick$7K
- Josephine MachadoNew Brunswick$7K
- Remya JamesNew Brunswick$7K
- Anna HaEnglewood$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.